Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-006472
Filing Date
2020-11-13
Accepted
2020-11-13 09:15:58
Documents
97
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 856273
2 CERTIFICATION curr_ex311.htm EX-31.1 9402
3 CERTIFICATION curr_ex312.htm EX-31.2 10481
4 CERTIFICATION curr_ex321.htm EX-32.1 4168
5 CERTIFICATION curr_ex322.htm EX-32.2 4168
12 curr_10qimg2.jpg GRAPHIC 2910
  Complete submission text file 0001477932-20-006472.txt   5666274

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20200930.xml EX-101.INS 1014486
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20200930.xsd EX-101.SCH 90146
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20200930_lab.xml EX-101.LAB 470150
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20200930_cal.xml EX-101.CAL 74819
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20200930_pre.xml EX-101.PRE 415461
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20200930_def.xml EX-101.DEF 242867
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 201309406
SIC: 2673 Plastics, Foil & Coated Paper Bags